Home / Health / Nafisa Ali Sodhi: Targeted Therapy Replaces Chemo
Nafisa Ali Sodhi: Targeted Therapy Replaces Chemo
14 Sep
Summary
- Nafisa Ali Sodhi's cancer treatment shifted to targeted therapy.
- Her ovarian/peritoneal cancer has progressed to new liver deposits.
- Targeted therapy targets specific molecular changes in cancer cells.
Actress Nafisa Ali Sodhi recently announced a significant change in her cancer treatment protocol. She has moved from chemotherapy to targeted therapy to combat her ovarian/peritoneal cancer, which has shown progression with new deposits on her liver. This new approach focuses on specific molecular targets that fuel cancer cell growth.
Dr. Puneet Gupta, Chairman of Oncology Services at Asian Hospital, clarified that while chemotherapy broadly targets rapidly dividing cells, targeted therapy is more precise. Eligibility for targeted therapy depends on molecular testing of the tumor to identify specific actionable targets. The progression of cancer, in this context, means the disease has grown or new areas have appeared despite treatment.
Deposits on the liver surface are distinct from primary liver cancer. In ovarian cancer, these surface deposits can indicate advanced disease spreading within the abdominal cavity. Oncologists use imaging scans like PET/CT in conjunction with a patient's overall clinical picture to determine the exact stage and optimal treatment plan.
